The role of intravenous iron in anemia management and transfusion avoidance. (manokatra rohy)

Auerbach M, Goodnough LT, Picard D, Maniatis A.

Loharanon-kevitra‎: Transfusion 2008;48(5):988-1000.

Rakitra‎: PubMed 18346021

DOI‎: 10.1111/j.1537-2995.2007.01633.x

https://www.ncbi.nlm.nih.gov/pubmed/18346021 (manokatra rohy)

The short-term use of erythropoetin-stimulating agents: impact on the biochemical recurrence of prostate cancer. (manokatra rohy)

Djavan B, Laze J, Eckersberger E, Finkelstein J, Agalliu I, Lepor H.

Loharanon-kevitra‎: BJU Int 2011;108(10):1582-7.

Rakitra‎: PubMed 21443653

DOI‎: 10.1111/j.1464-410X.2011.10173.x

https://www.ncbi.nlm.nih.gov/pubmed/21443653 (manokatra rohy)

The preoperative use of erythropoietin stimulating proteins prior to radical prostatectomy is not associated with increased cardiovascular or thromboembolic morbidity or mortality. (manokatra rohy)

Lepor H, Lipkin M, Slova D.

Loharanon-kevitra‎: Urology 2010;75(6):1424-8.

Rakitra‎: PubMed 20513505

DOI‎: 10.1016/j.urology.2009.06.095

https://www.ncbi.nlm.nih.gov/pubmed/20513505 (manokatra rohy)

Comparison of two different doses of preoperative recombinant erythropoietin in men undergoing radical retropubic prostatectomy. (manokatra rohy)

Nieder AM, Rosenblum N, Lepor H.

Loharanon-kevitra‎: Urology 2001;57(4):737-41.

Rakitra‎: PubMed 11306393

https://www.ncbi.nlm.nih.gov/pubmed/11306393 (manokatra rohy)